These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 19419637)

  • 21. [Nosocomial acquisition of Clostridium difficile infections].
    Feldman J; Yaretzky A; Alterman P
    Harefuah; 1994 Feb; 126(3):121-5, 176. PubMed ID: 8168741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
    Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
    J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile-associated diarrhoea.
    Elliott B; Chang BJ; Golledge CL; Riley TV
    Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with outbreak of Clostridium difficile 027].
    Olesen B
    Ugeskr Laeger; 2010 Mar; 172(12):952. PubMed ID: 20334786
    [No Abstract]   [Full Text] [Related]  

  • 25. Clostridium difficile and fluoroquinolones: is there a link?
    Weiss K
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular epidemiology and laboratory diagnosis of Clostridium difficile-associated diarrhea].
    Kato H
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2003; 14(2):121-6. PubMed ID: 15552833
    [No Abstract]   [Full Text] [Related]  

  • 27. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emergence of Clostridium difficile PCR ribotype 027 in Denmark--a possible link with the increased consumption of fluoroquinolones and cephalosporins?
    Søes L; Mølbak K; Strøbaek S; Truberg Jensen K; Torpdahl M; Persson S; Kemp M; Olsen KE
    Euro Surveill; 2009 Apr; 14(15):. PubMed ID: 19371514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology of severe Clostridium difficile infections in Hesse, Germany in 2008-2009].
    Arvand M; Hauri AM; Zaiss NH; Witte W; Bettge-Weller G
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1963-7. PubMed ID: 20922636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the changing face of Clostridium difficile disease for health care practitioners.
    McFarland LV; Beneda HW; Clarridge JE; Raugi GJ
    Am J Infect Control; 2007 May; 35(4):237-53. PubMed ID: 17482995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection control measures to limit the spread of Clostridium difficile. Introduction.
    Riley TV; Huovinen P
    Clin Microbiol Infect; 2008 May; 14 Suppl 5():1. PubMed ID: 18412709
    [No Abstract]   [Full Text] [Related]  

  • 32. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile.
    Kazakova SV; Ware K; Baughman B; Bilukha O; Paradis A; Sears S; Thompson A; Jensen B; Wiggs L; Bessette J; Martin J; Clukey J; Gensheimer K; Killgore G; McDonald LC
    Arch Intern Med; 2006 Dec 11-25; 166(22):2518-24. PubMed ID: 17159019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile diarrhea: infection control in horses.
    Båverud V
    Vet Clin North Am Equine Pract; 2004 Dec; 20(3):615-30. PubMed ID: 15519822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.
    Goorhuis A; Bakker D; Corver J; Debast SB; Harmanus C; Notermans DW; Bergwerff AA; Dekker FW; Kuijper EJ
    Clin Infect Dis; 2008 Nov; 47(9):1162-70. PubMed ID: 18808358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning.
    Beaulieu M; Thirion DJ; Williamson D; Pichette G
    Clin Infect Dis; 2006 Mar; 42(5):725; author reply 727-9. PubMed ID: 16447122
    [No Abstract]   [Full Text] [Related]  

  • 36. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on clostridium difficile-associated diarrhea suspected as nosocomial infection in urology ward].
    Ishida K; Yuhara K; Kanimoto Y; Ishihara S; Deguchi T
    Hinyokika Kiyo; 2005 May; 51(5):305-8. PubMed ID: 15977595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.
    Roberts S; Heffernan H; Al Anbuky N; Pope C; Paviour S; Camp T; Swager T
    N Z Med J; 2011 Apr; 124(1332):45-51. PubMed ID: 21747423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile--a continually evolving and problematic pathogen.
    Dawson LF; Valiente E; Wren BW
    Infect Genet Evol; 2009 Dec; 9(6):1410-7. PubMed ID: 19539054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
    Freeman J; Baines SD; Saxton K; Wilcox MH
    J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.